Gut Bacteria and Vegetable Benefits Depend on Microbial Chemistry

Gut Bacteria and Vegetable Benefits Produce Dinitrosyl Iron Complexes

A preclinical study from [Karolinska Institutet](https://ki.se/en), published in [Cell](https://www.cell.com) and reported via [ScienceDaily](https://www.sciencedaily.com/releases/2026/08/260822015145.htm), shows that gut microbes convert dietary nutrients into protective metabolic compounds. Intestinal bacteria bind dietary nitrate with plant-derived non-haem iron during digestion to form dinitrosyl iron complexes (DNICs). The researchers confirmed that these newly formed molecules enter circulation and travel to major organs, concentrating in the liver and kidneys.

This process requires two common dietary inputs that frequently appear in plant-forward diets. Leafy greens such as spinach, rocket, and lettuce alongside beetroot provide inorganic nitrate. Legumes, whole grains, and green vegetables provide the non-haem iron required to complete the chemical bond.

Preclinical Disease Models Show Measurable Metabolic Improvements

Administering dinitrosyl iron complexes to animal models of cardiometabolic disease improves blood pressure, vascular health, and blood glucose regulation. Researchers tested these effects in mice by providing oral supplements of nitrate and iron or by administering synthetically manufactured complexes directly. Animals receiving the compounds demonstrated reduced fat accumulation in liver tissue alongside improved endothelial vascular function.

The findings offer a mechanistic explanation for longstanding epidemiological observations regarding plant-rich diets. Senior researcher Andrei L. Kleschyov and cardiorenal physiology professor Mattias Carlström indicated that this microbial pathway directly supports organ health. The combination of dietary nitrate and non-haem iron provides the required substrates for ongoing molecular synthesis.

Gut Bacteria and Vegetable Benefits Disappear in Germ-Free Models

Germ-free mice lack dinitrosyl iron complexes entirely, demonstrating that gut bacteria and vegetable benefits require an active intestinal microbiome. When researchers examined tissues from germ-free animals, the protective complexes were absent despite the presence of dietary precursors. Living bacteria must carry out the chemical transformation for the complexes to appear.

Investigators confirmed the pathway across multiple experimental systems, including cultured bacterial cells and human tissue samples. Research teams from the [University Medical Centre Hamburg-Eppendorf](https://www.uke.de/english/) and the [Johannes Gutenberg University Medical Centre Mainz](https://www.unimedizin-mainz.de/index.php?la=2) collaborated on the tissue analyses. Their data confirms that dietary nitrate and iron cannot assemble into protective complexes without microbial intervention.

• Germ-free and colonized mouse models tested for tissue complex absorption
• Bacterial cell cultures evaluated for chemical conversion capacity
• Human biological samples analyzed to verify compound presence

Human Trials Must Validate How Gut Bacteria and Vegetable Benefits Work

Current evidence for dinitrosyl iron complexes originates in preclinical animal and cell models rather than randomized human trials. Researchers cannot yet measure these complexes routinely in clinical settings or determine exact target concentrations for human patients. Developing reliable clinical assays represents the immediate research objective before dietary or microbial therapies can be evaluated.

The research received funding from the Swedish Research Council, the Swedish Heart-Lung Foundation, the Novo Nordisk Foundation, and the European Research Council (ERC). The authors declared no financial conflicts of interest. Readers managing metabolic conditions should speak with a physician before drastically altering their dietary intake to support gut bacteria and vegetable benefits.

• Preclinical animal models do not guarantee identical response rates in humans.
• Standardized laboratory methods to measure circulating human complex levels remain in development.
• Specific bacterial strains responsible for the conversion in humans remain under investigation.